Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Faller

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|August 14, 2020
Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition AssayThomas Knoepfel, Pierre Nimsgern, Sébastien Jacquier, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2018
Development of autotaxin inhibitors: A series of zinc binding triazolesChristopher G Thomson, Darren Le Grand, Mark Dowling, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Structure-Based Optimization of a Fragment-like TLR8 Binding Screening Hit to an <i>In Vivo</i> Efficacious TLR7/8 AntagonistClaudia Betschart, Michael Faller, Florence Zink, et al.
ACS Medicinal Chemistry Letters|August 16, 2023
Discovery of the TLR7/8 Antagonist MHV370 for Treatment of Systemic Autoimmune DiseasesPhil Alper, Claudia Betschart, Cédric André, et al.
Blood Cancer Journal|July 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myelomaEllen Weisberg, Basudev Chowdhury, Chengcheng Meng, et al.
Nature Chemical Biology|January 19, 2021
BET bromodomain inhibitors regulate keratinocyte plasticityGabi Schutzius, Christian Kolter, Sebastian Bergling, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|August 14, 2020
Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition AssayThomas Knoepfel, Pierre Nimsgern, Sébastien Jacquier, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2018
Development of autotaxin inhibitors: A series of zinc binding triazolesChristopher G Thomson, Darren Le Grand, Mark Dowling, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Structure-Based Optimization of a Fragment-like TLR8 Binding Screening Hit to an <i>In Vivo</i> Efficacious TLR7/8 AntagonistClaudia Betschart, Michael Faller, Florence Zink, et al.
ACS Medicinal Chemistry Letters|August 16, 2023
Discovery of the TLR7/8 Antagonist MHV370 for Treatment of Systemic Autoimmune DiseasesPhil Alper, Claudia Betschart, Cédric André, et al.
Blood Cancer Journal|July 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myelomaEllen Weisberg, Basudev Chowdhury, Chengcheng Meng, et al.
Nature Chemical Biology|January 19, 2021
BET bromodomain inhibitors regulate keratinocyte plasticityGabi Schutzius, Christian Kolter, Sebastian Bergling, et al.
Pageof 2